A recent blood-based hepatitis C virus assay on Nuclein's DASH system highlighted its on-device sample prep, among other features that have been driving its adoption.
Backers claim the tests can predict a child’s risk of autism using a strand of hair or a mother’s blood, but critics say they are not ready for the market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback